{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:19Z","timestamp":1788527959640,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154333","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:00:39Z","timestamp":1784934039000},"page":"154333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations"],"prefix":"10.1016","volume":"833","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7733-0971","authenticated-orcid":false,"given":"Tushar","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0851-4156","authenticated-orcid":false,"given":"Priyanka","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6670-1956","authenticated-orcid":false,"given":"Chinmayee","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-513X","authenticated-orcid":false,"given":"Sheeba","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-1958","authenticated-orcid":false,"given":"Pradeep","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrc.2026.154333_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0163-7258(00)00097-8","article-title":"Purine nucleoside phosphorylases: properties, functions, and clinical aspects","volume":"88","author":"Bzowska","year":"2000","journal-title":"Pharmacol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2026.154333_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/znc-1990-1-211","article-title":"Properties of purine nucleoside phosphorylase (PNP) of mammalian and bacterial origin","volume":"45","author":"Bzowska","year":"1990","journal-title":"Z. Naturforsch. C Biosci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib3","first-page":"45","article-title":"Purine nucleoside phosphorylase deficiency","volume":"3","author":"Markert","year":"1991","journal-title":"Immunodeficiency Rev."},{"issue":"12","key":"10.1016\/j.bbrc.2026.154333_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJM197703242961203","article-title":"Purine nucleoside phosphorylase deficiency is associated with selective cellular immunodeficiency","volume":"296","author":"Stoop","year":"1977","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154333_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF01968126","article-title":"Inhibition of purine nucleoside phosphorylase activity and of T-cell function with allopurinol-riboside","volume":"9","author":"Nishida","year":"1979","journal-title":"Agents Actions"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s43042-024-00581-8","article-title":"Purine nucleoside phosphorylase (PNP) deficiency: across-the-board severe combined immunodeficiency","volume":"25","author":"Chohayeb","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"24","key":"10.1016\/j.bbrc.2026.154333_bib7","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1073\/pnas.88.24.11540","article-title":"Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors","volume":"88","author":"Ealick","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154333_bib8","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/S0021-9258(18)93353-3","article-title":"Inhibition of human purine nucleoside phosphorylase: studies with intact erythrocytes and the purified enzyme","volume":"243","author":"Krenitsky","year":"1968","journal-title":"J. Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.bbrc.2026.154333_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0925-4439(02)00073-X","article-title":"Development of transition state analogs of purine nucleoside phosphorylase as anti-T-cell agents","volume":"1587","author":"Schramm","year":"2002","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154333_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3960\/jslrt.25032","article-title":"A therapeutic effect of Forodesine for CNS relapsed primary testicular T cell lymphoma after allogeneic transplantation","volume":"65","author":"Tsutsumi","year":"2025","journal-title":"J. Clin. Exp. Hematop."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib11","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1038\/s41467-025-58221-7","article-title":"Metabolic constraint of human telomere length by nucleotide salvage efficiency","volume":"16","author":"Mannherz","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154333_bib12","series-title":"Forodesine (FodosineTM), a PNP Inhibitor Active in Relapsed or Refractory T-Cell Leukemia Patients (Phase II Study)","author":"Furman","year":"2005"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154333_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2174\/138955707781662636","article-title":"Forodesine (BCX-1777, immucillin H), a new purine nucleoside analogue: mechanism of action and potential clinical application","volume":"7","author":"Korycka","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"issue":"6_Supplement","key":"10.1016\/j.bbrc.2026.154333_bib14","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2024-5865","article-title":"Characterization and resistance mechanisms of the PNP inhibitor forodesin in forodesin-resistant cell lines","volume":"84","author":"Hosono","year":"2024","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154333_bib15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/molecules28030928","article-title":"Design and synthesis of new modified flexible purine bases as potential inhibitors of Human PNP","volume":"28","author":"Khandazhinskaya","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154333_bib16","first-page":"123","article-title":"ULODESINE Purine nucleoside phosphorylase inhibitor Rec INN; USAN Treatment of gout","volume":"39","author":"Gras","year":"2014","journal-title":"Drugs Future"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154333_bib17","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/acs.jpcb.0c10553","article-title":"Symmetric nucleosides as potent purine nucleoside phosphorylase inhibitors","volume":"125","author":"Pant","year":"2021","journal-title":"J. Phys. Chem. B"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154333_bib18","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2006-03-007468","article-title":"Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells","volume":"108","author":"Balakrishnan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.154333_bib19","first-page":"S8","article-title":"Pharmacology and mechanism of action of forodesine, a T-cell targeted agent","volume":"34","author":"Gandhi","year":"2007"},{"issue":"8","key":"10.1016\/j.bbrc.2026.154333_bib20","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1073\/pnas.071050798","article-title":"Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes","volume":"98","author":"Kicska","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00277-018-3418-2","article-title":"Multicenter phase 1\/2 study of forodesine in patients with relapsed peripheral T cell lymphoma","volume":"98","author":"Maruyama","year":"2019","journal-title":"Ann. Hematol."},{"issue":"24","key":"10.1016\/j.bbrc.2026.154333_bib22","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1021\/jm100597c","article-title":"Diadenosine 5\u2032, 5\u2032\u2032-(boranated) polyphosphonate analogues as selective nucleotide pyrophosphatase\/phosphodiesterase inhibitors","volume":"53","author":"Eliahu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02171744","article-title":"PNP inhibitors","volume":"2","author":"Montgomery","year":"1994","journal-title":"Perspect. Drug Discov. Des."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154333_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3_suppl","key":"10.1016\/j.bbrc.2026.154333_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350100603S01","article-title":"An introduction to nucleoside and nucleotide analogues","volume":"6","author":"Squires","year":"2001","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154333_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.376","article-title":"An overview of marketed nucleosides and nucleotides","volume":"2","author":"De Jonghe","year":"2022","journal-title":"Curr. Protoc."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154333_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.tibtech.2019.04.003","article-title":"Oligonucleotide analogs and mimics for sensing macromolecular biocompounds","volume":"37","author":"Bartold","year":"2019","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/anie.199000361","article-title":"Replication experiments with nucleotide base analogues","volume":"29","author":"Tamm","year":"1990","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154333_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101345","article-title":"Recent advances in nucleotide analogue-based techniques for tracking dividing stem cells: an overview","volume":"297","author":"Solius","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154333_bib30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2174\/092986733011230106124249","article-title":"Nucleoside and nucleotide analogues as potential therapeutics","volume":"30","author":"Pawlowska","year":"2023","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154333_bib31","series-title":"Molecular Engineering of Novel Nucleotide Analogues for DNA Sequencing by Synthesis","author":"Wu","year":"2008"},{"key":"10.1016\/j.bbrc.2026.154333_bib32","first-page":"1","article-title":"Microbial biosynthesis of nucleoside analogs: applications and engineering optimization","author":"Yu","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2026.154333_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1051525","article-title":"Nucleobase-modified nucleosides and nucleotides: applications in biochemistry, synthetic biology, and drug discovery","volume":"10","author":"Berdis","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbrc.2026.154333_bib34","doi-asserted-by":"crossref","DOI":"10.1039\/D5SC03026A","article-title":"Preparation of nucleoside analogues: opportunities for innovation at the interface of synthetic chemistry and biocatalysis","author":"Salihovic","year":"2025","journal-title":"Chem. Sci."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154333_bib51","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2217\/fon.10.83","article-title":"Forodesine: review of preclinical and clinical data","volume":"6","author":"Al-Kali","year":"2010","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/WNF.0b013e318204cd90","article-title":"Cladribine: mode of action and implications for treatment of multiple sclerosis","volume":"34","author":"Leist","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154333_bib53","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154333_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"de Sousa Cavalcante","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154333_bib55","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0149-2918(02)80058-3","article-title":"Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection","volume":"24","author":"Fung","year":"2002","journal-title":"Clin. Ther."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154333_bib56","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-015-0381-2","article-title":"Ledipasvir\/Sofosbuvir: a review of its use in chronic hepatitis C","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.bbrc.2026.154333_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9343(82)90055-9","article-title":"Mechanism of action and selectivity of acyclovir","volume":"73","author":"Elion","year":"1982","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154333_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/cells15020130","article-title":"Enhancing the nucleoside analog response with translational therapeutic approaches to overcome resistance","volume":"15","author":"Thibodeau","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2026.154333_bib36","series-title":"Drug Repurposing and Computational Drug Discovery","first-page":"27","article-title":"Approaches, strategies, and advances in computational drug discovery and drug repurposing","author":"Sharma","year":"2023"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154333_bib37","first-page":"1","article-title":"Computational strategies for designing peptide therapeutics with high binding affinity and stability","volume":"8","author":"Bhandari","year":"2024","journal-title":"Int. Rev. Experiment. Sci. Sci. Discov. Technol. Adv."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154333_bib38","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/molecules25061375","article-title":"A review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154333_bib39","article-title":"Decoding ROCK1 inhibition: a comprehensive computational analysis of key binding determinants for rational design of novel neurotherapeutics","author":"Gupta","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154333_bib40","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1039\/D5MD00361J","article-title":"EGFR AP: a predictive machine learning model for assessing small molecule activity against the epidermal growth factor receptor","volume":"16","author":"Gupta","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154333_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2174\/1573409916666201023113709","article-title":"In silico approach for exploring the role of AT1R polymorphism on its function, structure and drug interactions","volume":"17","author":"Sharma","year":"2021","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.bbrc.2026.154333_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151575","article-title":"Determining the effect of natural compounds on mutations of pyrazinamidase in multidrug-resistant tuberculosis: illuminating the dark tunnel","volume":"756","author":"Singh","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154333_bib43","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1021\/acs.jcim.5c00625","article-title":"Refining the trapping of therapeutic agent Silybin A in functionalized \u03b2-and \u03b3-Cyclodextrin cavitands for improved supramolecular complexation","volume":"65","author":"Kumar","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.154333_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151614","article-title":"Enhanced sampling simulations to explore himalayan phytochemicals as potential phosphodiesterase-1 inhibitor for neurological disorders","volume":"758","author":"Sharma","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/07391102.2023.2192805","article-title":"2D-QSAR, molecular docking and MD simulation based virtual screening of the herbal molecules against Alzheimer's disorder: an approach to predict CNS activity","volume":"42","author":"Thakur","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154333_bib46","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1080\/07391102.2023.2204492","article-title":"Computational investigation of the impact of potential AT2R polymorphism on small molecule binding","volume":"42","author":"Sharma","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154333_bib47","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/ja9093692","article-title":"Enhanced conformational space sampling improves the prediction of chemical shifts in proteins","volume":"132","author":"Markwick","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154333_bib48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/toxics12110822","article-title":"Recent advances in omics, computational models, and advanced screening methods for drug safety and efficacy","volume":"12","author":"Son","year":"2024","journal-title":"Toxics"},{"issue":"12","key":"10.1016\/j.bbrc.2026.154333_bib49","article-title":"Nucleotide and nucleoside-based drugs: past, present, and future","volume":"29","author":"Al Awadh","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154333_bib50","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1021\/acs.jproteome.0c00392","article-title":"Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase, a key drug target for COVID-19","volume":"19","author":"Chien","year":"2020","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154333_bib59","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.bbrc.2003.08.094","article-title":"Structural basis for inhibition of human PNP by immucillin-H","volume":"309","author":"de Azevedo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.bbrc.2026.154333_bib60","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1107\/S0907444998009378","article-title":"Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules","volume":"54","author":"Sussman","year":"1998","journal-title":"Biol. Crystall."},{"issue":"suppl_1","key":"10.1016\/j.bbrc.2026.154333_bib61","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"suppl_1","key":"10.1016\/j.bbrc.2026.154333_bib62","doi-asserted-by":"crossref","first-page":"D145","DOI":"10.1093\/nar\/gkj084","article-title":"MODOMICS: a database of RNA modification pathways","volume":"34","author":"Dunin-Horkawicz","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154333_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.601065","article-title":"RASPD+: fast protein-ligand binding free energy prediction using simplified physicochemical features","volume":"7","author":"Holderbach","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbrc.2026.154333_bib64","series-title":"Chemical Biology: Methods and Protocols","first-page":"243","article-title":"Small-molecule library screening by docking with PyRx","author":"Dallakyan","year":"2014"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/acs.jctc.6b00931","article-title":"Gaussian accelerated molecular dynamics in NAMD","volume":"13","author":"Pang","year":"2017","journal-title":"J. Chem. Theor. Comput."},{"issue":"15","key":"10.1016\/j.bbrc.2026.154333_bib66","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1021\/acs.jcim.5c01063","article-title":"Recent developments in amber biomolecular simulations","volume":"65","author":"Case","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.154333_bib67","article-title":"Molecular mechanism underlying conformations and region communications of periplasmic receptor affected by diversity of phosphate groups","author":"Chen","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154333_bib68","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1021\/acs.jcim.4c01174","article-title":"Conformations of KRAS4B affected by its partner binding and G12C mutation: insights from GaMD trajectory-image transformation-based deep learning","volume":"64","author":"Chen","year":"2024","journal-title":"J. Chem. Inf. Model."},{"issue":"16","key":"10.1016\/j.bbrc.2026.154333_bib69","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154333_bib70","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side\u2010chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff\u2010Larsen","year":"2010","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154333_bib71","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/acs.jctc.8b01039","article-title":"Assessment of GAFF2 and OPLS-AA general force fields in combination with the water models TIP3P, SPCE, and OPC3 for the solvation free energy of druglike organic molecules","volume":"15","author":"Vassetti","year":"2019","journal-title":"J. Chem. Theor. Comput."},{"issue":"20","key":"10.1016\/j.bbrc.2026.154333_bib72","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bbrc.2026.154333_bib73","doi-asserted-by":"crossref","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154333_bib74","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0021-9991(89)90160-5","article-title":"A modified shake algorithm for maintaining rigid bonds in molecular dynamics simulations of large molecules","volume":"85","author":"Lambrakos","year":"1989","journal-title":"J. Comput. Phys."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154333_bib75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5257","article-title":"SG\u2010ML\u2010PLAP: a structure\u2010guided machine learning\u2013based scoring function for protein\u2013ligand binding affinity prediction","volume":"34","author":"Pal","year":"2025","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154333_bib77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acs.jcim.7b00650","article-title":"K deep: protein\u2013ligand absolute binding affinity prediction via 3d-convolutional neural networks","volume":"58","author":"Jim\u00e9nez","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"47","key":"10.1016\/j.bbrc.2026.154333_bib78","doi-asserted-by":"crossref","first-page":"13486","DOI":"10.1021\/jp507629n","article-title":"Conformational behavior of flavin adenine dinucleotide: conserved stereochemistry in bound and free states","volume":"118","author":"Kuppuraj","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pro.5560070102","article-title":"Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs","volume":"7","author":"Mewies","year":"1998","journal-title":"Protein Sci."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154333_bib80","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1021\/acs.jmedchem.2c02097","article-title":"Design, synthesis, biological evaluation, and crystallographic study of novel purine nucleoside phosphorylase inhibitors","volume":"66","author":"Skacel","year":"2023","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154333_bib81","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","article-title":"Analysis of protein folding simulation with moving root mean square deviation","volume":"63","author":"Maruyama","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"6\u20137","key":"10.1016\/j.bbrc.2026.154333_bib82","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.camwa.2004.11.022","article-title":"Ranking fuzzy numbers with an area method using radius of gyration","volume":"51","author":"Deng","year":"2006","journal-title":"Comput. Math. Appl."},{"key":"10.1016\/j.bbrc.2026.154333_bib83","series-title":"LigPlot+: Multiple ligand\u2013protein Interaction Diagrams for Drug Discovery","author":"Laskowski","year":"2011"},{"key":"10.1016\/j.bbrc.2026.154333_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.revip.2017.05.001","article-title":"Strategies for the exploration of free energy landscapes: unity in diversity and challenges ahead","volume":"2","author":"Pietrucci","year":"2017","journal-title":"Rev. Phys."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154333_bib85","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/acs.jctc.1c00974","article-title":"Protein\u2013protein interaction-Gaussian accelerated molecular dynamics (PPI-GaMD): characterization of protein binding thermodynamics and kinetics","volume":"18","author":"Wang","year":"2022","journal-title":"J. Chem. Theor. Comput."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154333_bib86","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1021\/ct500090q","article-title":"Improved reweighting of accelerated molecular dynamics simulations for free energy calculation","volume":"10","author":"Miao","year":"2014","journal-title":"J. Chem. Theor. Comput."},{"issue":"16","key":"10.1016\/j.bbrc.2026.154333_bib87","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160852","article-title":"Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity","volume":"132","author":"Abt","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib88","first-page":"143","article-title":"Immunodeficiency caused by purine nucleoside phosphorylase deficiency","volume":"20","author":"Cohen","year":"2000","journal-title":"Immunol. Allergy Clin."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154333_bib89","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the amyloid-\u03b2 peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrc.2026.154333_bib90","article-title":"Symmetrization of the backbone of nucleic acids: a molecular dynamics study","author":"Pant","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154333_bib91","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.bbrc.2020.08.097","article-title":"DNA triplex with conformationally locked sugar disintegrates to duplex: insights from molecular simulations","volume":"532","author":"Pant","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154333_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146968","article-title":"Bases immediate upstream of the TATAAT box of the sigma 70 promoter of Escherichia coli significantly influence the activity of a model promoter by altering the bending angle of DNA","volume":"851","author":"Sharma","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2026.154333_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2024.107273","article-title":"Flexible RNA aptamers as inhibitors of Bacillus anthracis ribosomal protein S8: insights from molecular dynamics simulations","volume":"312","author":"Pant","year":"2024","journal-title":"Biophys. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2026.154333_bib94","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1039\/C8SC00010G","article-title":"Exploring PAZ\/3\u2032-overhang interaction to improve siRNA specificity: a combined experimental and modeling study","volume":"9","author":"Alagia","year":"2018","journal-title":"Chem. Sci."},{"issue":"20","key":"10.1016\/j.bbrc.2026.154333_bib95","first-page":"9990","article-title":"Protein-DNA interfaces: a molecular dynamics analysis of time-dependent recognition processes for three transcription factors","volume":"44","author":"Etheve","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.154333_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106525","article-title":"Marshall's nucleic acid: from double-helical structure to a potent intercalator","volume":"269","author":"Pant","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bbrc.2026.154333_bib97","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1021\/acs.jpcb.3c04788","article-title":"Probing the nucleic acid flexibility to disarm the viral counter-defense machinery: design and characterization of potent p19 inhibitors","volume":"127","author":"Pant","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbrc.2026.154333_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400768","article-title":"Design and characterization of neutral linker-based bis-intercalator via computer simulations: balancing DNA binding and cellular uptake","author":"Pant","year":"2024","journal-title":"Chem. Biodivers."},{"issue":"48","key":"10.1016\/j.bbrc.2026.154333_bib99","doi-asserted-by":"crossref","first-page":"9956","DOI":"10.1021\/acs.jpcb.2c04527","article-title":"Harmonizing interstrand electrostatic repulsion by conformational rigidity in counterion-deprived Z-DNA: a molecular dynamics study","volume":"126","author":"Pant","year":"2022","journal-title":"J. Phys. Chem. B"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154333_bib100","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1080\/07391102.2022.2061594","article-title":"Bicyclo-DNA mimics with enhanced protein binding affinities: insights from molecular dynamics simulations","volume":"41","author":"Pant","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.154333_bib101","article-title":"Modeling DNA opening in the eukaryotic transcription initiation complexes via coarse-grained models","volume":"8","author":"Shino","year":"2021","journal-title":"Front. Mol. Biosci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:45:45Z","timestamp":1788525945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26010971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":101,"alternative-id":["S0006291X26010971"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154333","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing nucleos(t)ide analogs as purine nucleoside phosphorylase inhibitors through Gaussian accelerated molecular dynamics simulations","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154333"}}